Current IACM-Bulletins
The IACM-Bulletin is a FREE bi-weekly e-mail newsletter, covering news topics on all aspects of Cannabis as medicine. To receive IACM-Bulletin per e-mail, please subscribe online.
[IACM Homepage] [IACM-Bulletin Year 2023] [2021] [2020] [2019] [2018] [2017] [2016] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000]
- IACM-Bulletin of 04 December 2022
- Science/Human: Cannabis may be helpful in the treatment of children with autism
- Science/Human: Cannabis legalisation was associated with lower use of opioids in cancer patients
- Science/Human: A transdermal CBD gel improved symptoms in fragile X syndrome according to controlled study
- Science/Human: Palmitoylethanolamide improved diabetic-related neuropathic pain in a placebo-controlled trial
- IACM-Bulletin of 19 November 2022
- USA: Voters in Maryland and Missouri approved the legalisation of cannabis for use by adults
- Science/Human: Cannabis may improve quality for life in treatment-resistant fibromyalgia women
- Science/Human: Cannabis may improve quality of life in Tourette’s syndrome according to a survey
- Science/Human: Cannabis may improve pain and reduce inflammation
- Science/Human: CBD may reduce mood and sleep in patients with anxiety disorder
- Science/Human: Patients with treatment refractory chronic pain may profit from cannabis
- IACM-Bulletin of 05 November 2022
- Science/Human: Cannabis may be helpful in the treatment of emotionally unstable personality disorder according to a case series
- Science/Human: The use of cannabis is associated with a lower risk of metabolic disorders in people infected with the hepatitis C virus
- Science/Human: Cannabis use improves quality of life according to an observational data review
- Science/Human: The inhalation of THC rich cannabis flowers but not the intake of the CBD extract reduces chronic low back pain
- Science/Human: Cannabis use in people living with HIV was associated with increased physical activity
- Science/Human: Cannabis may be very effective against headache according to a survey
- IACM-Bulletin of 23 October 2022
- IACM: The IACM honoured four researchers at the Cannabinoid Conference 2022
- Science/Human: The use of cannabis is associated with reduced opioid use
- Science/Human: The medical use of cannabis may reduce nightmares in patients with post-traumatic stress disorder
- Science/Human: The use of cannabis may improve symptoms of inflammatory bowel disease
- Science/Human: Cannabis is well tolerated by older adults with dementia and improves symptoms
- Science/Human: Patients with advanced cancer may profit from a treatment with a water soluble preparation of THC and CBD
- Science/Human: There may be no differences in psychotic symptomatology between cannabis users and non-users
- Science/Human: A CBD gel was associated with significant improvement in pain of patients with lumbar spinal stenosis
- IACM-Bulletin of 09 October 2022
- USA: President Joe Biden pardons thousands of people with federal offenses for simple cannabis possession
- Science/Human: CBD-rich cannabis oil reduced agitation related to dementia in a placebo-controlled study
- Science/Human: Medical cannabis patients report health improvements and reductions in opioid use
- Science/Human: Medical cannabis is usually well tolerated by older adults
- Science/Human: Cannabis use is associated with a lower rate of persistent opioid use after total joint arthroplasty.
- Science/Human: CBD-rich cannabis oil was effective in adults with drug-resistant focal epilepsy
- Science/Human: Cannabis-based medicines may improve symptoms in autism spectrum disorder
- Science/Human: Sex differences in relief of cancer symptoms by cannabis
- Science/Human: Cannabis use was associated with reduced severe acute respiratory syndrome in corona virus 2 infection in pregnant women
- IACM-Bulletin of 25 September 2022
- Science/Human: Cannabis may improve autism symptoms
- Science/Human: A CBD-rich cannabis extract improved symptoms in drug-resistant epilepsy
- Science/Human: Oleoylethanolamide may improve clinical outcome in stroke patients according to a controlled study
- Science/Human: Palmitoylethanolamide may improve negative symptoms in patients with schizophrenia
- IACM-Bulletin of 11 September 2022
- IACM: Conference attendees to receive additional free IACM membership
- Science/Human: Legalisation of cannabis in the US leads to big revenue losses for pharmaceutical companies
- Science/Human: THC may be beneficial in Tourette syndrome according to a controlled study
- Science/Human: Cannabis use in gastroparesis is associated with lower risk of vomiting
- Science/Human: CBD may be helpful in the treatment of joint pain
- IACM-Bulletin of 28 August 2022
- Science/Human: Cannabis improves abdominal pain in gastroparesis
- Science/Human: CBD may be effective in the treatment of joint pain according to a survey
- Science/Human: Cannabis use was protective against overweight in HIV-hepatitis C virus co-infected people
- Science/Human: Cannabis was associated with a lower risk of mortality in hospital in patients with gastroparesis
- Science/Human: CBD may prevent from chemotherapy-induced neuropathy in an open study
- Science/Human: Cannabis is effective in nausea and vomiting during pregnancy according to a survey
- Science/Human: THC may be helpful in the treatment of post-traumatic stress disorder according to a controlled study
- Science/Human: THC facilitates fear extinction learning
- Science/Human: Cannabis use is not associated with amotivation
- IACM-Bulletin of 14 August 2022
- Science/Human: Many women use cannabis for the treatment of menopause-related symptoms
- Science/Human: CBD may reduce symptoms of chemotherapy-induced peripheral neuropathy
- Science/Human: Cannabis may be helpful in palliative care
- Science/Human: Cannabis use may be associated with a lower COVID-19 severity in hospitalised patients according to a retrospective analysis
- Science/Human: The effect of cannabis on fibromyalgia may in part be explained by an improvement of mood
- Science/Human: CBD may be helpful in anxiety disorders
- Science/Human: Oral THC may be helpful in the treatment of chronic pain
- Science/Human: CBD may reduce pain after surgery according to a placebo-controlled study
- IACM-Bulletin of 17 July 2022
- Science/Human: Very low doses of a THC-rich cannabis extract improved memory in a patient with Alzheimer's disease
- Science/Human: Cannabis may be helpful in the treatment of fatigue according to and app-based survey
- Science/Human: Cannabis use does not reduce motivation
- Science/Human: Cannabis use was associated with less short-term medical complications after spinal surgery
- Science/Human: Cannabis is perceived helpful by patients with Parkinson’s disease
- Science/Human: Cannabis may reduce pain in musculoskeletal disorder according to a survey
- IACM-Bulletin of 19 June 2022
- Brasil: Superior Court of Justice authorised 3 patients to grow cannabis for medical treatment
- USA: Rhode Island becomes 19th state to legalize cannabis for adults
- Science/Human: Successful treatment of cutaneous squamous cell carcinoma with topical CBD
- Science/Human: Cannabis may be beneficial in anxiety and depression according to a large retrospective study
- Science/Human: Many Canadian pain patients use cannabis for symptom control
- Science/Human: Cannabis use is associated with lower corpulence in people with hepatitis C
- Science/Human: Cannabis intake with a new metered dose inhaler is effective in the treatment of chronic pain
- IACM-Bulletin of 05 June 2022
- Science/Human: Cannabis may be helpful in the treatment of nausea according to an app based study
- Science/Human: Topical CBD effective in the treatment of thump basal joint arthritis according to a controlled study
- Science/Human: Cannabis may alleviate symptoms associated with cancer
- Science/Human: CBD may show some efficacy in children with autism spectrum disorder according to a controlled study
- IACM-Bulletin of 22 May 2022
- Science/Human: Cannabis may be helpful against cancer pain according to an open study
- Science/Human: Cannabis may improve anxiety and depression according to retrospective study
- Science/Human: CBD cream may be helpful in psoriasis
- Science/Human: Cannabis preparations may be helpful in Parkinson’s disease
- Science/Human: Cannabis may be helpful in sleeping disorders according to small study
- Science/Human: Cannabis users with traumatic brain injury were at lesser risk for stroke than non-users
- Science/Human: Cannabis may be helpful for the treatment of nausea during pregnancy
- Science/Human: The legalisation of cannabis in the state of Washington was associated with reduced use of alcohol and tobacco in youth
- Science/Human: Many patients with upper extremity conditions use cannabis in Canada
- IACM-Bulletin of 24 April 2022
- Science/Human: Cannabis may be helpful in inflammatory bowel disease according to survey
- Science/Human: The legalisation of cannabis for adults may be associated with reduced prescription drug use
- Science/Human: A cannabis extract was superior to long acting opiates in patients with neuropathic back pain
- IACM-Bulletin of 10 April 2022
- IACM: The Cannabinoid Conference 2022 is dedicated to Daniela Parolaro
- IACM: Former Chairwoman Daniela Parolaro passed away
- USA: House of Representatives supports the legalisation of cannabis, but the bill faces dim prospects in the Senate
- Science/Human: THC reduces opioid use in older pain patients even in low doses
- Science/Human: The legalisation of cannabis in the USA did not increase cannabis-related treatments
- Science/Human: Cannabidivarin may be effective in the treatment of epilepsy in girls with Rett syndrome
- IACM-Bulletin of 27 March 2022
- Science/Human: Cannabis may be helpful in Tourette syndrome according to an open study
- Science/Human: The anxiolytic effect of CBD depends on the nature of trauma in post-traumatic stress disorder
- Science/Human: Cannabis is effective in the treatment of nausea according to self-reports
- Science/Human: Cannabis use is common in patients with hair loss and helps them cope with anxiety and depression
- IACM-Bulletin of 13 February 2022
- USA: Mississippi becomes the 37th state to legalise the medical use of cannabis
- Science/Human: Cannabis may be helpful in the treatment of chronic migraine according to a retrospective study
- Science/Human: A cannabis extract and pure THC reduce pain according to two analyses from the German Pain e-Registry
- Science/Human: Patients with neuropathic pain may benefit from a treatment with cannabis
- Science/Human: Cannabis use is associated with decreased mortality in trauma patients
- IACM-Bulletin of 16 January 2022
- Science/Cells: Cannabinoids may have the potential to prevent and treat infection by the new coronavirus
- Science/Human: Among older adults in Canada medicinal cannabis products are more often used by women than by men
- Science/Human: Cannabis is used for a variety of medical reasons in the USA and Canada
- Science/Human: Fatal outcome in a clinical study with the new FAAH inhibitor in healthy adults
- IACM-Bulletin of 02 January 2022
- Science/Human: The medical use of cannabis may be helpful in severe treatment resistant epilepsy
- Science/Human: CBD in addition to THC in cannabis cigarettes reduces anxiety while keeping positive subjective effects
- Science/Animal: CBD inhibits growth of glioblastoma by altering the tumour microenvironment among other mechanisms
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.